6.4.3 Women and menopause: Understanding decision-making around HRT (126)
Sharron Hinchliff, Lecturer, School of Nursing and Midwifery, University of Sheffield, Sheffield, United Kingdom Co authors: Merryn Gott & Fiona Wilson s.hinchliff@sheffield.ac.uk
Abstract:
Background:
A small number of studies have explored women’s views on hormone replacement therapy (HRT) since the Women’s Health Institute published its findings on the treatment’s potential adverse effects. Very little research, however, has been qualitative and/or UK-based.
Aim:
Drawing on women’s own perspectives, this paper will examine decision-making around HRT.
Method:
In-depth interviews were conducted with 47 women, aged 48 to 61, registered with GPs in Barnsley (21 had never used HRT, 20 had used it previously and 6 were using at the time of interview). Data were analysed thematically. Results Participants were divided in their awareness of the risks associated with HRT, and whether or not this knowledge prevented use was mixed. Reasons for not using HRT included: bodily changes not perceived as severe; not wanting to interfere with the naturalness of menopause; and a dislike of medicines. The primary reason for choosing HRT was to alleviate ‘symptoms’ participants attributed to menopause, which many had tolerated until they felt unable to cope. Decisions to discontinue HRT were based upon concerns about future risks to health, part their own experience and part the result of stories in the media, alongside ineffectiveness of HRT.
Discussion:
Although some women will choose not to use HRT, others will in order to alleviate ‘symptoms’ that interfere with daily life, believing that the benefits outweigh the risks. Whilst the majority of participants were aware of the benefits of HRT, not all were aware of the risks. These findings will usefully inform women’s decision-making, and are of value to clinical practice, especially practice nurses who are a point of contact for women seeking advice on menopause.
Conclusion:
Decision-making around HRT was often difficult, and shaped by physical ‘symptoms’, awareness of risks and benefits associated with HRT as well as the social context within which participants experienced menopause.
Source of Funding: UK – Industry
Amount in Funding: 50,001 - 100,000
Biography:
Sharron Hinchliff is a lecturer at the School of Nursing & Midwifery, University of Sheffield. Her research interests are in gender, ageing and sexuality.